scholarly journals Endoscopic screening for gastric cancer in Japan: Current status and future perspective

2021 ◽  
Author(s):  
Katsuhiro Mabe ◽  
Kazuhiko Inoue ◽  
Tomoari Kamada ◽  
Katsuaki Kato ◽  
Mototsugu Kato ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Current Status ◽  
Future Perspective ◽  
Endoscopic Screening

scholarly journals Current status and future perspective of perioperative chemotherapy for localized gastric cancer

2016 ◽  
Vol 27 ◽  
pp. vii12
Author(s):  
Kensei Yamaguchi ◽  
Keisho Chin ◽  
Daisuke Takahari ◽  
Takashi Ichimura
Keyword(s):  
Gastric Cancer ◽  
Current Status ◽  
Future Perspective ◽  
Perioperative Chemotherapy

scholarly journals Current status and future perspective of artificial intelligence applications in endoscopic diagnosis and management of gastric cancer

2020 ◽  
Author(s):  
Toshiaki Hirasawa ◽  
Yohei Ikenoyama ◽  
Mitsuaki Ishioka ◽  
Ken Namikawa ◽  
Yusuke Horiuchi ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Gastric Cancer ◽  
Endoscopic Diagnosis ◽  
Current Status ◽  
Future Perspective ◽  
Diagnosis And Management

scholarly journals Liquid Biopsy: Current Status and Future Perspective in Gastric Cancer andHelicobacterInfection

2018 ◽  
Vol 18 (3) ◽  
pp. 150 ◽  
Author(s):  
Eun A Kang ◽  
Young Min Han ◽  
Jong Min Park ◽  
In Kyung Yoo ◽  
Sung Pyo Hong ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Liquid Biopsy ◽  
Current Status ◽  
Future Perspective

Current status and development of miRNA and siRNA research on gastric cancer

2011 ◽  
Vol 33 (9) ◽  
pp. 925-930 ◽  
Author(s):  
Miao HE ◽  
Zi-Wei WANG
Keyword(s):  
Gastric Cancer ◽  
Current Status

BIOPSY OF THE SIGNALING LYMPH NODES IN GASTRIC CANCER - CURRENT STATUS OF THE PROBLEM AND PROSPECTS

2018 ◽  
Vol 64 (3) ◽  
pp. 335-344
Author(s):  
Aleksey Karachun ◽  
Yuriy Pelipas ◽  
Oleg Tkachenko ◽  
D. Asadchaya
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Lymph Nodes ◽  
Stomach Cancer ◽  
Current Status ◽  
Regional Lymph Nodes ◽  
Systematic Analysis ◽  
Tumor Spread ◽  
Special Value

The concept of biopsy of sentinel lymph node as the first lymph node in the pathway of lymphogenous tumor spread has been actively discussed over the past decades and has already taken its rightful place in breast and melanoma surgery. The goal of this method is to exclude vain lymphadenectomy in patients without solid tumor metastases in regional lymph nodes. In the era of minimally invasive and organ-saving operations interventions it seems obvious an idea to introduce a biopsy of sentinel lymph node in surgery of early gastric cancer. Meanwhile the complexity of lymphatic system of the stomach and the presence of so-called skip metastases are factors limiting the introduction of a biopsy of sentinel lymph node in stomach cancer. This article presents a systematic analysis of biopsy technology of signaling lymph node as well as its safety and oncological adequacy. Based on literature data it seems to us that the special value of biopsy of sentinel lymph nodes in the future will be in the selection of personalized surgical tactics for stomach cancer.

Current Status and Future Perspective for Research on Medicinal Plants with Anticancerous Activity and Minimum Cytotoxic Value

2019 ◽  
Vol 20 (12) ◽  
pp. 1227-1243
Author(s):  
Hina Qamar ◽  
Sumbul Rehman ◽  
D.K. Chauhan
Keyword(s):  
Side Effects ◽  
Medicinal Plants ◽  
Anticancer Agents ◽  
Drug Targets ◽  
Psidium Guajava ◽  
Current Status ◽  
Future Perspective ◽  
Wide Range

Cancer is the second leading cause of morbidity and mortality worldwide. Although chemotherapy and radiotherapy enhance the survival rate of cancerous patients but they have several acute toxic effects. Therefore, there is a need to search for new anticancer agents having better efficacy and lesser side effects. In this regard, herbal treatment is found to be a safe method for treating and preventing cancer. Here, an attempt has been made to screen some less explored medicinal plants like Ammania baccifera, Asclepias curassavica, Azadarichta indica, Butea monosperma, Croton tiglium, Hedera nepalensis, Jatropha curcas, Momordica charantia, Moringa oleifera, Psidium guajava, etc. having potent anticancer activity with minimum cytotoxic value (IC50 >3μM) and lesser or negligible toxicity. They are rich in active phytochemicals with a wide range of drug targets. In this study, these medicinal plants were evaluated for dose-dependent cytotoxicological studies via in vitro MTT assay and in vivo tumor models along with some more plants which are reported to have IC50 value in the range of 0.019-0.528 mg/ml. The findings indicate that these plants inhibit tumor growth by their antiproliferative, pro-apoptotic, anti-metastatic and anti-angiogenic molecular targets. They are widely used because of their easy availability, affordable price and having no or sometimes minimal side effects. This review provides a baseline for the discovery of anticancer drugs from medicinal plants having minimum cytotoxic value with minimal side effects and establishment of their analogues for the welfare of mankind.

Emerging 3D printing technologies for drug delivery devices: Current status and future perspective

2021 ◽  
Author(s):  
Jiawei Wang ◽  
Yu Zhang ◽  
Niloofar Heshmati Aghda ◽  
Amit Raviraj Pillai ◽  
Rishi Thakkar ◽  
...  
Keyword(s):  
Drug Delivery ◽  
3D Printing ◽  
Current Status ◽  
Future Perspective ◽  
Drug Delivery Devices
Sign in / Sign up

Export Citation Format

Share Document